The study, published in the Journal of Neuroscience, administered a hydrogel treatment to rats with spinal cord injuries, which greatly improved axonal outgrowth across the lesions.
Hydrogel features a soluble agonist called S-220 that triggers a molecule called Epac2, which experts believe is involved in nerve growth during embryonic development
The hydrogel provides a scaffold that supports injured nerve cells during the regeneration process and led to a significant improvement in the rats’ ability to walk.
More articles on spine:
5 orthopedic expansion projects costing $200M+
5 recent telemedicine developments for spine, orthopedics
Dr. Scott Boden: Telemedicine can achieve spine success if ‘reimbursement barriers are reduced’
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
